Miraculins Inc, a Canadian company focused on developing and commercializing medical diagnostic tests for unmet clinical needs, announces the finalization of a research collaboration agreement with Diagnostic Technologies Ltd (DTL).
Read MoreChembio Diagnostic Systems Inc has been awarded a small Business Innovative Research (SBIR) Phase II grant to fully develop, validate, and commercialize a rapid diagnostic test for leptospirosis for general use worldwide.
Read MoreNew CDC data released today indicate far too many people are diagnosed with HIV late in the course of infection, when neither treatment nor prevention can have optimal benefit.
Read More
How the stimulus bill could ease out-of-pocket costs for labs.
Read More
Crucial details are yet to come, but billions in health care dollars will likely affect clinical laboratories in ways both direct and indirect.
Read More